|
A falsely elevated high-sensitivity troponin i (tnih) patient result was obtained on an advia centaur cp instrument.The result was reported to the physician(s).The customer used the same instrument and an alternate advia centaur cp to perform repeat.The customer obtained similar lower results on both instruments.The repeat results were considered correct, and a corrected report was issued.Siemens investigated the event log and noted no flag or error when the advia centaur cp ran the sample.Siemens inspected the sample and observed suspended particles in the serum sample.The customer stated that the patient tested tnih from (b)(6) 2024 to (b)(6) 2024, and suspended particles were in three samples.Siemens dispatched a customer service engineer (cse).The cse replaced the wash 1 pump, performed testing, noted that the tnih imprecision did not recur, and resolved the issue.Siemens reviewed the information provided, which included the tnih ifu, and confirmed the following: do not to use specimens with apparent contamination.Before placing samples in the system, ensure that samples are free of bubbles or foam, fibrin, or other particulate matter.If clotting time is increased due to thrombolytic or anticoagulant therapy, using serum samples may increase the risk of micro-clots, fibrin, or particulate matter.Siemens noted the cse performed the necessary hardware inspection and services as part of troubleshooting and noted no recurrence.The sample integrity cannot be ruled out as the potential cause for the falsely elevated result.The advia centaur cp analyzer is operating as specified.No further action was required.
|